Ann: Security Class Reinstatement to Quotation- OPTOB, page-600

Yes, Regeneron $130B down to $72B in market cap—that’s USD, mind you. Now, what would they shell out to claw back that $60B in missing market cap, eh? That’s right USD again, just shy of AUD$100B gone missing . They would certainly like it back

Now listen closely, I’ve got this little gem of an Aussies biotech company. If its P3 trials come through, if the products are combined it’s a 20-year money-spinner. Puts them back at the top where they belong. What’s it worth, you ask? I’d say 50% of AUD$100B, just a bargain at AUD$50B that's fair and reasonable a steal at $38 a share, I would take cash or script, I am not greedy.